BC3 Technologies Inc
Founded in 2018 in Baltimore, BC3 Technologies is a minority-owned enterprise dedicated to revolutionizing emergency medical response. The company focuses on addressing critical gaps in emergency medical care, particularly in the management of life-threatening arterial bleeding, through innovative hemostatic solutions. BC3 Technologies aims to save lives by providing efficient, effective, and accessible products for medical, military, and general consumer sectors.
BC3 Technologies Inc
3701-A Southwestern Blvd, Baltimore MD, 21229
What We Do
Aerosolized Hemostatic Products
Development and commercialization of aerosolized hemostatic products designed to manage serious arterial bleeding effectively and efficiently.
Emergency Medical Solutions
Providing innovative solutions for emergency medical response, particularly in trauma care and wound management.
An FDA-cleared aerosolized chitosan product for rapid management of serious arterial bleeding, designed for use by first responders and in surgical environments.
A planned version of the SEAL Hemostatic Wound Spray tailored for veterinary use, aimed at improving animal care in emergency situations.